Literature DB >> 7529062

Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional.

E S Choi1, J L Nichol, M M Hokom, A C Hornkohl, P Hunt.   

Abstract

An in vitro culture system demonstrating the transitions from megakaryocyte progenitors to functional platelets is described. CD34-selected cells from normal human peripheral blood are cultured under conditions that promote megakaryocyte formation. After 8 to 11 days, enriched populations of mature megakaryocytes are replated under conditions that favor the development of proplatelets. Proplatelets express the platelet-specific proteins, glycoproteins Ib and IIb (GPIb and GPIIb), and fibrinogen and also contain microtubule coils equal in size to those found in plasma-derived platelets. In addition, proplatelets have ultrastructural features in common with plasma-derived platelets. Platelet-sized particles from the proplatelet culture supernatants are examined. Ultrastructurally, these particles are identical to plasma-derived platelets. Functionally, these culture-derived platelets aggregate in response to both thrombin and adenosine diphosphate (ADP) plus fibrinogen. This aggregation is specifically inhibited by the addition of a function-blocking anti-GPIIbIIIa antibody. Culture-derived platelets stimulated with agonists also express the activation-dependent antigens P-selectin and functional fibrinogen receptor. This is the first description of an in vitro culture system that sequentially demonstrates megakaryocyte growth, development, and platelet production.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529062

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  79 in total

Review 1.  The end is just the beginning: megakaryocyte apoptosis and platelet release.

Authors:  J Li; D J Kuter
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

2.  Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling.

Authors:  Koji Eto; Ronan Murphy; Steve W Kerrigan; Alessandra Bertoni; Heidi Stuhlmann; Toru Nakano; Andrew D Leavitt; Sanford J Shattil
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

Review 3.  Lonely in Paris: when one gene copy isn't enough.

Authors:  Ramesh A Shivdasani
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 4.  Does size matter in platelet production?

Authors:  Jonathan N Thon; Joseph E Italiano
Journal:  Blood       Date:  2012-06-04       Impact factor: 22.113

5.  Infusion of mature megakaryocytes into mice yields functional platelets.

Authors:  Rudy Fuentes; Yuhuan Wang; Jessica Hirsch; Cheng Wang; Lubica Rauova; G Scott Worthen; M Anna Kowalska; Mortimer Poncz
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

Review 6.  [Current models of thrombopoiesis].

Authors:  H Schulze
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 7.  Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets.

Authors:  Xiuli Sim; Mortimer Poncz; Paul Gadue; Deborah L French
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

8.  Differential roles of microtubule assembly and sliding in proplatelet formation by megakaryocytes.

Authors:  Sunita R Patel; Jennifer L Richardson; Harald Schulze; Eden Kahle; Niels Galjart; Ksenija Drabek; Ramesh A Shivdasani; John H Hartwig; Joseph E Italiano
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

9.  Thrombopoietin expands hematopoietic stem cells after transplantation.

Authors:  Norma Fox; Greg Priestley; Thalia Papayannopoulou; Kenneth Kaushansky
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 10.  Challenges and promises for the development of donor-independent platelet transfusions.

Authors:  Michele P Lambert; Spencer K Sullivan; Rudy Fuentes; Deborah L French; Mortimer Poncz
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.